Full Title
Quadruplet Induction Followed by Teclistamab Consolidation and Doublet Maintenance in Patients with Primary Plasma Cell Leukemia: The QUANTUM Trial (A062401) (CIRB)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Hani Hassoun’s office at 646-608-3718.
Protocol
26-368
Phase
Phase II (phase 2)
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07605416
ClinicalTrials.gov